by Market Overview:
Bacterial vaccines provide immunity against various bacterial pathogens. They help prevent infectious diseases like pneumonia, meningitis, tetanus, diphtheria, pertussis, and tuberculosis. These vaccines boost immunity in a cost-effective manner with minimal side effects.
Market key trends:
One of the key trends in the bacterial vaccines market is the rising focus on development of combination bacterial vaccines. Combination vaccines provide protection against multiple infectious diseases with a single injection, thereby improving patient compliance. Combination bacterial vaccines are more convenient as they reduce the number of required injections. For instance, DTaP-IPV-Hib and PCV13 vaccines provide protection against 7-10 diseases with a single dose. This reduces healthcare costs and chances of hospitalization due to infectious diseases. Rising incidence of diseases like pertussis and meningitis is also driving the demand for combination bacterial vaccines.
SWOT Analysis
Strength: Bacterial vaccines are effective in preventing infectious diseases like diphtheria, pertussis, tetanus etc. which helps reduce the disease burden. They trigger memory immune response and provide long lasting protection against bacterial diseases.
Weakness: The efficacy of bacterial vaccines may vary depending on individual’s immune response. Development of bacterial vaccines requires complex manufacturing process and high capital investment.
Opportunity: Rising incidence of bacterial infections due to air pollution, environmental changes is increasing the demand for effective bacterial vaccines. Growing awareness about vaccine preventable diseases is also expanding the market scope.
Threats: Emergence of antibiotic resistant bacterial strains poses challenges in vaccine development. Stringent regulatory processes for vaccine approval can delay market launch.
Key Takeaways
The Global Bacterial Vaccines Market Demand is expected to witness high growth, exhibiting CAGR of 8.0% over the forecast period, due to increasing burden of bacterial diseases worldwide. Factors such as growing prevalence of respiratory infections, meningitis and pneumonia are also driving the market growth.
Regional analysis
North America is expected to dominate the global bacterial vaccines market during the forecast period. This is attributed to the advancements in biotechnology sector, strong healthcare infrastructure and rapid adoption of new vaccine technologies. Asia Pacific region is anticipated to exhibit fastest growth owing to large population base, improving healthcare access and initiatives by government agencies to strengthen immunization programs.
Key players
Key players operating in the bacterial vaccines market are GlaxoSmithKline plc, Pfizer Inc., Merck & Co. Inc., Sanofi Pasteur SA, Johnson & Johnson, Serum Institute of India Pvt. Ltd., Bharat Biotech International Limited, Biological E. Limited, Astellas Pharma Inc., Seqirus (CSL Limited), Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Bavarian Nordic, Emergent BioSolutions Inc., Valneva SE. Major companies are focusing on new product launches and acquisitions to strengthen their market presence.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
